These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23651231)

  • 21. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis.
    Rasmussen JB; Glennow C
    Eur Respir J; 1988 Apr; 1(4):351-5. PubMed ID: 3294038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]).
    Pasupathy S; Tavella R; Grover S; Raman B; Procter NEK; Du YT; Mahadavan G; Stafford I; Heresztyn T; Holmes A; Zeitz C; Arstall M; Selvanayagam J; Horowitz JD; Beltrame JF
    Circulation; 2017 Sep; 136(10):894-903. PubMed ID: 28634219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial].
    Correa MJ; Mariz HA; Andrade LE; Kayser C
    Rev Bras Reumatol; 2014; 54(6):452-8. PubMed ID: 25458027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial.
    Skvarc DR; Dean OM; Byrne LK; Gray LJ; Ives K; Lane SE; Lewis M; Osborne C; Page R; Stupart D; Turner A; Berk M; Marriott AJ
    Trials; 2016 Aug; 17():395. PubMed ID: 27502769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of N-acetylcysteine on the cardiac remodeling biomarkers and major adverse events following acute myocardial infarction: a randomized clinical trial.
    Talasaz AH; Khalili H; Fahimi F; Jenab Y; Broumand MA; Salarifar M; Darabi F
    Am J Cardiovasc Drugs; 2014 Feb; 14(1):51-61. PubMed ID: 24105017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of N-acetylcysteine in prevention of noise induced hearing loss: a randomized clinical trial.
    Kopke R; Slade MD; Jackson R; Hammill T; Fausti S; Lonsbury-Martin B; Sanderson A; Dreisbach L; Rabinowitz P; Torre P; Balough B
    Hear Res; 2015 May; 323():40-50. PubMed ID: 25620313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.
    Hardan AY; Fung LK; Libove RA; Obukhanych TV; Nair S; Herzenberg LA; Frazier TW; Tirouvanziam R
    Biol Psychiatry; 2012 Jun; 71(11):956-61. PubMed ID: 22342106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Orally Administered N-Acetylcysteine on Chronic Bronchitis: A Meta-analysis.
    Wei J; Pang CS; Han J; Yan H
    Adv Ther; 2019 Dec; 36(12):3356-3367. PubMed ID: 31598901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial.
    Fraga CM; Tomasi CD; Damasio DC; Vuolo F; Ritter C; Dal-Pizzol F
    Crit Care; 2016 Oct; 20(1):331. PubMed ID: 27745551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial.
    Sepehrmanesh Z; Heidary M; Akasheh N; Akbari H; Heidary M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():289-296. PubMed ID: 29126981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A multi-center clinical study of N-acetylcysteine on chronic hepatitis B].
    Shi XF; Guo SH; Wu G; Mao Q; Yu YS; Wang JK; Zhang L; Wang ZY; Zhang XQ; Zhang QH; Zhao YR; Zeng WQ
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):20-3. PubMed ID: 15670485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study.
    Grant JE; Odlaug BL; Kim SW
    Arch Gen Psychiatry; 2009 Jul; 66(7):756-63. PubMed ID: 19581567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-Acetylcysteine in psychodermatological disorders.
    Nwankwo CO; Jafferany M
    Dermatol Ther; 2019 Sep; 32(5):e13073. PubMed ID: 31444827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia (nail biting).
    Leonard HL; Lenane MC; Swedo SE; Rettew DC; Rapoport JL
    Arch Gen Psychiatry; 1991 Sep; 48(9):821-7. PubMed ID: 1929772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study.
    Sarris J; Oliver G; Camfield DA; Dean OM; Dowling N; Smith DJ; Murphy J; Menon R; Berk M; Blair-West S; Ng CH
    CNS Drugs; 2015 Sep; 29(9):801-9. PubMed ID: 26374743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The application of n-acetylcysteine as an antioxidant and mucolytic in mechanical ventilation in intensive care patients. A prospective, randomized, placebo-controlled, double-blind study].
    Konrad F; Schoenberg MH; Wiedmann H; Kilian J; Georgieff M
    Anaesthesist; 1995 Sep; 44(9):651-8. PubMed ID: 7485927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial.
    Klauser P; Xin L; Fournier M; Griffa A; Cleusix M; Jenni R; Cuenod M; Gruetter R; Hagmann P; Conus P; Baumann PS; Do KQ
    Transl Psychiatry; 2018 Oct; 8(1):220. PubMed ID: 30315150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Auricular Acupressure Improves Habit Reversal Treatment for Nail Biting.
    Sun D; Reziwan K; Wang J; Zhang J; Cao M; Wang X; Wang X; Liu J; Li B; Dilimaolati R; Zhong L; Liu Y
    J Altern Complement Med; 2019 Jan; 25(1):79-85. PubMed ID: 30183329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study.
    Molnár Z; Shearer E; Lowe D
    Crit Care Med; 1999 Jun; 27(6):1100-4. PubMed ID: 10397212
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.